Abstract:Multidrug resistance (MDR) remains one of the major reasons for the reductions in efficacy of many chemotherapeutic agents in cancer therapy. As a classical MDR phenotype of human malignancies, the adenosine triphosphate binding cassette (ABC)-transporter P-glycoprotein (MDR1/P-gp) is an efflux protein with aberrant activity that has been linked to multidrug resistance in cancer. For the reversal of MDR by RNA interference (RNAi) technology, an U6-RNA gene promoter-driven expression vector encoding anti-MDR1/P-gp short hairpin RNA (shRNA) molecules was constructed (abbreviated pDNA-iMDR1-shRNA). This study explored the feasibility of using Pluronic P123-conjugated polypropylenimine (PPI) dendrimer (P123-PPI) as a carrier for pDNA-iMDR1-shRNA to overcome tumor drug resistance in breast cancer cells. P123-PPI functionalized with anti-CD44 monoclonal antibody (CD44 receptor targeting ligand) (anti-CD44-P123-PPI) can efficiently condense pDNA into nanocomplexes to achieve efficient delivery of pDNA, tumor specificity and long circulation. The in vitro studies methodically evaluated the effect of P123-PPI and anti-CD44-P123-PPI on pDNA-iMDR1-shRNA delivery and P-gp downregulation. Our in vitro results indicated that the P123-PPI/pDNA and anti-CD44-P123-PPI/pDNA nanocomplexes with low cytotoxicity revealed higher transfection efficiency compared with the PPI/pDNA nanocomplexes and Lipofectamine™ 2000 in the presence of serum. The nanocomplexes loaded with pDNA-iMDR1-shRNA against P-gp could reverse MDR accompanied by the suppression of MDR1/P-gp expression at the mRNA and protein levels and improve the internalization and cytotoxicity of Adriamycin (ADR) in the MCF-7/ADR multidrug-resistant cell line. BALB/c nude mice bearing MCF-7/ADR tumor were utilized as a xenograft model to assess antitumor efficacy in vivo. The results demonstrated that the administration of anti-CD44-P123-PPI/pDNA-iMDR1-shRNA nanocomplexes combined with ADR could inhibit tumor growth more efficiently than ADR alone. The enhanced therapeutic efficacy of ADR may be correlated with increased accumulation of ADR in drug-resistant tumor cells. Consequently, these results suggested that the use of pDNA-iMDR1-shRNA-loaded nanocomplexes may be a promising gene delivery strategy to reverse MDR and improve the effectiveness of chemotherapy.

shRNA-mediated construction of RNAi expression plasmid and its inhibitory effect on MDR1 expression in hepatocellular carcinoma cell SMMC-7721/R

Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer]

Construction and identification of vector against Kir6.2 gene expression in hepatoma cells by short interfering RNAs

BC047440 Gene Silencing Inhibits the Proliferation of HepG2 Cells

[Reversal of leukemia multidrug resistance by sequence-specific short hairpin RNA]

Lentiviral Mir30-Based Rna Interference Against Heparanase Suppresses Melanoma Metastasis With Lower Liver And Lung Toxicity

Short Hairpin RNA Expression Reversing MDR1 Gene-Dependent Multidrug Resistance of Human Breast Cancer Cell Line (Mcf-7/Adrr)

[Construction of Shrna Expression Vector Silencing Kir6.2 Gene and to Study Its Influence on the Proliferation and Invasion of HepG2 Cells].

Suppression of Mrp1 Expression and Restoration of Sensitivity to Chemotherapy in Multidrug-Resistant Hepatocellular Carcinoma Cell Lines HepG2/mrp1 by RNA Interference in Vitro

[Reversal of Multidrug Resistance of K562/A02 Cell Line by Mdr1 and GSTpi Gene Silence].

[Functional Study of Mdr1 and GSTpi Expression Reversed by Hairpin Sirna in K562/A02 Cell Line].

Inhibition of P-gp Expression in Amycin-resistant Human Erythroleukemia Cell Strain K562/ADM by Shrna Expression Vector

RNAi-based knockdown of multidrug resistance-associated protein 1 is sufficient to reverse multidrug resistance of human lung cells.

Screening effective sequences of small interfering RNAs targeting mrp1 gene in human HepG2/mrp1 cells

Construction of multidrug resistance hepatocellular carcinoma cell model

Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.

Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.

Reversal of Multidrug Resistance by Magnetic Fe3o4 Nanoparticle Copolymerizating Daunorubicin and Mdr1 Shrna Expression Vector in Leukemia Cells

Study on Inhibiting Expression of IGF1R in Hepatocellular Carcinoma Cells by Constructing Shrna Eukaryotic Expression Vectors

[Reversal of Multi-Drug Resistance in K562/A02 Cells by Small Interference RNA of Mdr1 Gene].

Rna Interference-Mediated Inhibition of Endogenous Survivin Expression in Hepatocarcinoma Cell